CDC42BPA and acute respiratory distress syndrome: Immunofluorescence staining demonstrated that lungs from ARDS patients (n = 5) express much lower levels of MRCKα compared with lungs from control donors (n = 3) (Supplemental Figure 5A and Figure 6A), with an average of 30% less relative fluorescent staining intensities (Figure 6B).